Suven Life Sciences Limited (NSE:SUVEN)
India · Delayed Price · Currency is INR 349.85
+13.40 (3.98%)
Sep 17, 2026, 3:29 PM IST
Suven Life Sciences Market Cap
Suven Life Sciences has a market cap or net worth of 88.76 billion as of September 17, 2026. Its market cap has increased by 73.26% in one year.
Market Cap
88.76B
Enterprise Value
83.74B
Revenue
88.14M
Ranking
n/a
PE Ratio
n/a
Stock Price
349.85
ChartMarket Cap Chart
Since July 31, 2002, Suven Life Sciences's market cap has increased from 1.61B to 88.76B, an increase of 5,407.62%. That is a compound annual growth rate of 18.06%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 16, 2026 | 88.76B | 133.85% |
| Dec 31, 2025 | 37.95B | 35.97% |
| Dec 31, 2024 | 27.91B | 58.69% |
| Dec 29, 2023 | 17.59B | 17.75% |
| Dec 30, 2022 | 14.94B | 31.72% |
| Dec 31, 2021 | 11.34B | -1.66% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Alivus Life Sciences | 170.22B |
| Cohance Lifesciences | 168.41B |
| Alembic Pharmaceuticals | 159.40B |
| NATCO Pharma | 146.04B |
| Sudeep Pharma | 135.85B |
| Akums Drugs and Pharmaceuticals | 118.86B |
| Strides Pharma Science | 109.08B |
| Aarti Pharmalabs | 74.97B |